Oncology

Efficacy of aromatase inhibitors reduced among breast cancer patients who smoke.

Top news of the day from across the healthcare landscape.

Study finds PRC2 inhibitor may treat wide range of cancer types.

Reading mammograms for longer periods of time did not reduce cancer detection, but increased overall performance.

Survival doubled in patients being treated with nivolumab, but the disease eventually progressed in most patients.

Study finds risk from drinking coffee, tea, or other beverages at higher temperatures.

Iso-acoustic focusing could be used to determine how a treatment is working in cancer patients.

Gene therapy found to stop the progression of glioblastoma and high-grade glioma in mouse models.

Promising new technique revealed for stopping tumor cell migration.

Researchers discovered that the gene RhoC is able to control how cancer cells create energy and use glutamine.

FCGR2A could indicate which patients with colorectal cancer respond to cetuximab.

Recommended levels of exercise found to decrease the risk of cancer in 13 of 26 cancer types.

Certain cancer cells evade the immune system through blocking NLRC5.

Issues with sleep can lead poor prognosis for skin cancer.

Several factors can affect whether women diagnosed with breast cancer begin chemotherapy.

Nanostructured lipid carriers containing melatonin adjuvant to tamoxifen killed more breast cancer cells than tamoxifen alone.

Hyaluronidase could stop elevated pressure in solid tumors, which is a major reason cancer drugs fail.

Patients with cancer need to be assessed for mental health issues.

Differences exist between cancer in males and females on a molecular level.

Quality measures for the management of NSCLC patients are only received by 13% of all eligible patients.

A combination of doxorubicin, all-trans retinoic acid, and entinostat shrank triple-negative breast cancer tumors by 90%.

Microfluidic device can help physicians determine optimal treatment of cancer.

Patients with 2a testicular seminoma show improved outcomes with radiation.

Discovery may determine the best therapeutic option for breast cancer patients.

Up to 25% of patients with lung cancer also have an autoimmune disease.

Treatment attacks brain tumor metabolism at several points.

The Comparative Toxicogenomics Database is able to identify genetically similar diseases and could repurpose medications to treat these conditions.

Top news of the day from across the health care landscape.